Trial intelligence / Profile preview

Mannitol inhalations as a faster procedure for testing of airways hyperresponsiveness

2006-003795-35Phase 3Active

Sponsor
University Medical Center Groningen
Start
Jul 2006
Modality
Small Molecules, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
Countries
1
01

Overview

Phase 3, open-label trial of Bronchitol in asthma and chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by University Medical Center Groningen. Primary endpoint: Time involved in measurement of hyperresponsiveness. Started Jul 2006; status: active.

02

Drugs

Bronchitol
03

Conditions

asthmachronic obstructive pulmonary disease (COPD)

Beyond the preview

Go deeper on 2006-003795-35.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-003795-35.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call